Concepedia

Klára Mezei

KM

Statistics

Publications

4

Citations

124

H-Index

4

Active since

2012

Affiliations

National Institute of Oncology(Current)

University of Nyíregyháza

Spectrum Pharmaceuticals (United States)

West Cancer Center

Klára Mezei is an author at National Institute of Oncology specializing in cancer therapeutics, radiation oncology, and breast cancer.

Top concepts

Publications per year

2012–2020

4

Publications

4

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

, , +7

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

Susan G. Urba, Carla M.L. van Herpen, Tarini Prasad Sahoo et al. · Cancer · 2012 · 44 citations · Full text

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study

Patrick Cobb, Yong Wha Moon, Klára Mezei et al. · Cancer Medicine · 2020 · 23 citations · Full text

An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer

Jeffrey Vacirca, Arlene Chan, Klára Mezei et al. · Cancer Medicine · 2018 · 11 citations · Full text

1–4 of 4